Accelerating Biopharmaceutical and Vaccine R&D with Genedata
May 5, 2025
Digital innovation in biopharmaceutical and vaccine R&D has the power to accelerate scientific progress and improve the overall success rate through better data integration, analysis, accessibility, and traceability. It also enables intelligent automation of experimental workflows.
In this poster, we present the Genedata Biopharma Platform, a dedicated enterprise solution that consists of seven software solutions, working separately and together to provide significant benefits in R&D. It integrates easily into existing IT environments using open APIs and promotes internal and external collaboration across organizations.
Genedata Biologics® and Genedata Screener® support key research workflows and assay analysis primarily in the earlier phases of R&D. Genedata Chromatics® streamlines chromatography data analysis workflows both in research and downstream process development. Genedata Bioprocess® and Genedata Selector® are utilized in bioprocess development, including CLD, USP, DSP, formulation, and analytics development. Genedata Profiler® supports translational research by streamlining the integration and analysis of multi-modal development and real-world data. Genedata Expressionist® is used for MS-based characterization and quality control of diverse biotherapeutics and vaccines throughout R&D.
